X4 Pharmaceuticals: HC Wainwright Raises Buy Rating to $5, PT from $3.5

lunes, 10 de noviembre de 2025, 7:17 am ET1 min de lectura
XFOR--

X4 Pharmaceuticals: HC Wainwright Raises Buy Rating to $5, PT from $3.5

X4 Pharmaceuticals: HC Wainwright Raises Buy Rating to $5, PT from $3.5

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios